benzobicyclo-octane-based TNF-alpha inhibitors (Celltech)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebenzobicyclo-octane-based TNF-alpha inhibitors (Celltech)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelltech R&D Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelltech R&D Ltd
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A